ID: ALA5282170

Max Phase: Preclinical

Molecular Formula: C30H47NO4S

Molecular Weight: 517.78

Representations

Canonical SMILES:  C=C[C@]1(C)C[C@@H](OC(=O)CS[C@@H]2CCC3CCC2N3C)[C@@]2(C)C3C(=O)CC[C@@]3(CC[C@H]2C)[C@@H](C)[C@@H]1O

Standard InChI:  InChI=1S/C30H47NO4S/c1-7-28(4)16-24(35-25(33)17-36-23-11-9-20-8-10-21(23)31(20)6)29(5)18(2)12-14-30(19(3)27(28)34)15-13-22(32)26(29)30/h7,18-21,23-24,26-27,34H,1,8-17H2,2-6H3/t18-,19+,20?,21?,23-,24-,26?,27+,28-,29+,30+/m1/s1

Standard InChI Key:  XPDWSVPFMYOLIJ-MOLMKHOXSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 517.78

Molecular Weight (Monoisotopic): 517.3226

AlogP: 5.25

#Rotatable Bonds: 5

Polar Surface Area: 66.84

Molecular Species: BASE

HBA: 6

HBD: 1

#RO5 Violations: 2

HBA (Lipinski): 5

HBD (Lipinski): 1

#RO5 Violations (Lipinski): 2

CX Acidic pKa:

CX Basic pKa: 9.33

CX LogP: 4.75

CX LogD: 2.83

Aromatic Rings: 0

Heavy Atoms: 36

QED Weighted: 0.40

Np Likeness Score: 1.71

References

1. Yong C, Yu J, Wu C, Zhang X, Li Y, Xie C, He X, Liu D, Wang Z, Lai P, Zhang Y..  (2023)  Design, Synthesis, and Biological Activity of Thioguanine-Modified Pleuromutilin Derivatives.,  14  (6): [PMID:37312858] [10.1021/acsmedchemlett.3c00004]

Source

Source(1):

• Scientific Literature